BioCentury
ARTICLE | Company News

ADImmune Corp., Crucell deal

March 26, 2007 7:00 AM UTC

ADImmune received an exclusive license to use CRXL's virosome technology to produce a virosomal adjuvanted influenza vaccine in Taiwan, Japan and Macau. ADImmune also will produce influenza antigen, ...